newsfilter
← Latest News
GlobeNewswire·

Reviva to Participate in Fireside Chat at A.G.P.'s Annual Healthcare Company Showcase

  • Reviva Pharmaceuticals Holdings, Inc. announced CEO Laxminarayan Bhat will participate in a fireside chat with analyst Jim Molloy at A.G.P.'s Annual Healthcare Company Showcase.
  • The fireside chat is scheduled for Wednesday, May 20, 2026, from 2:40 PM to 3:00 PM ET.
  • Reviva is a late-stage biopharmaceutical company focusing on central nervous system, inflammatory, & cardiometabolic diseases.
  • The company's pipeline includes two in-house discovered new chemical entities: brilaroxazine (RP5063) & RP1208.
  • Reviva holds composition of matter patents for both drug candidates in the United States, Europe, & several other countries.